|
Alnylam
@
Alnylam
Cambridge, MA
|
|
Alnylam is the world’s leading RNAi therapeutics company. We believe that patients living with life-threatening diseases deserve innovative new treatments.
|
|
|
2.216
Tweetovi
|
533
Pratim
|
11.472
Osobe koje vas prate
|
| Tweetovi |
|
Alnylam
@Alnylam
|
12 h |
|
Tomorrow (Thursday), we'll be sharing 4th Quarter and Full Year 2019 financial results during a LIVE webcast. A replay will be available at the link below later in the day.
|
||
|
|
||
|
Alnylam
@Alnylam
|
3. velj |
|
26 days until #RareDiseaseDay! But for the >300 million people worldwide living w/ a #raredisease, their families, friends, caregivers & healthcare professionals and those focused on developing new treatments, every day is rare disease day. Learn more about how to #ShowYourRare!
|
||
|
|
||
|
Alnylam
@Alnylam
|
31. sij |
|
We’re pleased to announce that we’ve received a positive opinion from the EMA (@EMA_News) Committee for Medicinal Products for Human Use (#CHMP) for our investigational #RNAi therapeutic for the treatment of the #raredisease acute hepatic #porphyria.
|
||
|
|
||
|
Alnylam
@Alnylam
|
30. sij |
|
Acute hepatic #porphyria (AHP) refers to a family of rare, often misdiagnosed genetic diseases characterized by potentially life-threatening attacks and, for some patients, chronic debilitating symptoms that negatively impact daily functioning and quality of life. #raredisease
|
||
|
|
||
| Alnylam proslijedio/la je tweet | ||
|
John Maraganore
@JMaraganore
|
29. sij |
|
Thanks @BostonGlobe and @damiangarde for highlighting the @Alnylam story as one of the successes in the Boston/Cambridge ecosystem! There is no better place in the world to make a medicine than right here! bostonglobe.com/2020/01/28/opi…
|
||
|
|
||
|
Alnylam
@Alnylam
|
22. sij |
|
Symptoms of acute hepatic #porphyria (AHP) can often lead to misdiagnoses of more common conditions such as IBS, fibromyalgia, appendicitis & endometriosis. As a result, patients often remain w/o a proper diagnosis for up to 15 yrs. #raredisease
|
||
|
|
||
| Alnylam proslijedio/la je tweet | ||
|
Global Genes
@GlobalGenes
|
16. sij |
|
What a week! Thank you partners and sponsors for supporting #2020RITS and #raredisease. @tradegovukUSA @Alnylam @GileadSciences @HorizonNews @Cydanco @genentech @Insmed @IpsenGroup @RetrophinRare @VertexPharma @AlexionPharma @MDAorg @demycolton @EBDgroup #CareAboutRare pic.twitter.com/99Tr0vGd4A
|
||
|
|
||
|
Alnylam
@Alnylam
|
15. sij |
|
We're #AlnylamProud to welcome our first Co-op class of the new decade! This outstanding group of 33 co-ops and legal externs represents @Northeastern, @UMassAmherst and @BU_Law. Learn more about career development at Alnylam here: bit.ly/2Li20kD pic.twitter.com/Pb3cjRBjyK
|
||
|
|
||
|
Alnylam
@Alnylam
|
13. sij |
|
PH1 of a Kind is a 4-part video series for kids, about kids from around the world who have been diagnosed with primary hyperoxaluria type 1 (PH1). The videos star Isabelle, Luuk, Asha and Will and each tackles a different challenge they face living with this #raredisease.
|
||
|
|
||
|
Alnylam
@Alnylam
|
12. sij |
|
This afternoon, we announced preliminary Q4 and full year 2019 global net product revenues and additional updates. Tune in to our live #JPM20 webcast tomorrow at 1:30 PM ET/10:30 AM PT to learn more. Access the webcast here: bit.ly/2R0JobX
|
||
|
|
||
|
Alnylam
@Alnylam
|
10. sij |
|
We're pleased to announce today that we've initiated a rolling submission of a New Drug Application (NDA) to the @US_FDA for lumasiran, an investigational #RNAi therapeutic for the treatment of primary #hyperoxaluria type 1 (PH1). #raredisease
|
||
|
|
||
|
Alnylam
@Alnylam
|
10. sij |
|
Peggy’s life partner Dan, who is living with #hATTR #amyloidosis, inspired her to convey the puzzling challenges of the disease through an original artwork as part of the “The Art of Living with hATTR Amyloidosis” project. They discuss their story in a new Q&A. #raredisease
|
||
|
|
||
|
Alnylam
@Alnylam
|
9. sij |
|
|
||
|
Alnylam
@Alnylam
|
8. sij |
|
People who may have the #raredisease primary #hyperoxaluria type 1 can talk to their doctor about Alnylam Act’s no-cost, 3rd-party genetic testing & counseling. Alnylam Act may help accelerate or confirm a PH1 diagnosis so families can make informed decisions about their health.
|
||
|
|
||
|
Alnylam
@Alnylam
|
8. sij |
|
New year! New role? We've got >150 open roles in the US, Europe and Asia including many in research, clinical development, clinical operations, quality, medical affairs and manufacturing. Perhaps this is YOUR moment to join a leader that is also a recognized top employer.
|
||
|
|
||
| Alnylam proslijedio/la je tweet | ||
|
John Maraganore
@JMaraganore
|
31. pro |
|
Thrilled to see the arrival of gene silencing medicines (our #RNAi therapeutics) included in this great recap of important breakthroughs in medical science in 2019 by @BBCNews!
bbc.com/news/health-50…
|
||
|
|
||
|
Alnylam
@Alnylam
|
2. sij |
|
“Living a Rare Life” is the story of one family’s journey to unlock the mysteries of a life-threatening genetic #raredisease called #hATTR #amyloidosis and how examining their health history across generations proved to be critical.
|
||
|
|
||
|
Alnylam
@Alnylam
|
2. sij |
|
As we enter the new decade, we look forward to seeing the incredible biomedical breakthroughs from our industry to come and look back with pride on our contribution to the innovations of the past decade. And #RNAi is just getting started! #biotech #raredisease
|
||
|
|
||
|
Alnylam
@Alnylam
|
26. pro |
|
Supporting patient access to innovative treatments is at the core of our Patient Access Philosophy and our head of Patient Services discusses how her team works with patients in many ways to help them navigate the evolving complexities of today’s healthcare system in a new Q&A.
|
||
|
|
||
|
Alnylam
@Alnylam
|
21. pro |
|
For many people, like CeCe, it can take years to be accurately diagnosed with #hATTR amyloidosis. Click the link below to learn more about CeCe’s story, the signs and symptoms of this #raredisease and the importance of having meaningful conversations with your doctor.
|
||
|
|
||